Connection
Ashley Frazer-Abel to Complement Pathway, Alternative
This is a "connection" page, showing publications Ashley Frazer-Abel has written about Complement Pathway, Alternative.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.250 |
|
|
|
-
McCaleb ML, Hughes SG, Grossman TR, Frazer-Abel A, Jung B, Yin L, Henry SP, Monia BP, Schneider E, Geary R, Brice GT. Inhibiting the alternative pathway of complement by reducing systemic complement factor B: Randomized, double-blind, placebo-controlled phase 1 studies with Sefaxersen. Immunobiology. 2025 03; 230(2):152876.
Score: 0.218
-
Thurman JM, Frazer-Abel A, Holers VM. The Evolving Landscape for Complement Therapeutics in Rheumatic and Autoimmune Diseases. Arthritis Rheumatol. 2017 11; 69(11):2102-2113.
Score: 0.033